A Phase II Trial of Gemcitabine plus Capecitabine for Patients with Advanced Pancreatic Cancer

Overview of attention for article published in Cancer Research and Treatment : Official Journal of Korean Cancer Association, June 2012

Altmetric Badge

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 14 Mendeley

Summary Dimensions citations

So far, Dimensions has found 9 publications that cite this research output.

9

The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.

Results of a prospective phase 2 clinical trial of induction gemcitabine/capecitabine followed by stereotactic ablative radiation therapy in borderline resectable or locally advanced pancreatic adenocarcinoma

Article in Practical Radiation Oncology (October 2017)

A randomized, multicenter, phase III study of gemcitabine combined with capecitabine versus gemcitabine alone as first-line chemotherapy for advanced pancreatic cancer in South Korea

Article in Medicine (January 2017)

An Updated Meta-analysis and System Review:is Gemcitabine+Fluoropyrimidine in Combination a Better Therapy Versus Gemcitabine Alone for Advanced and Unresectable Pancreatic Cancer?

Article in Asian Pacific Journal of Cancer Prevention (September 2015)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.